THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS
Saved in:
CAVANAGH, R., ET AL., THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS. JOURNAL OF PSYCHOACTIVE DRUGS, Vol. 21, no. 2 (1989), p. 217-220.
Ref.
11225
Location:
SIIS R.829 Depósito (106/107)
Palabras clave:
Drogodependencias, Enfermedades mentales, Fármacos, Trastornos de atención
Drogodependencias, Enfermedades mentales, Fármacos, Trastornos de atención
Similar Items: THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS
- RECOGNIZING AND TREATING ATTENTION DEFICIT DISORDERS IN CHEMICALLY DEPENDENT ADOLESCENTES
- DIAGNOSING ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND LEARNING DISABILITIES WITH CHEMICALLY DEPENDENT ADOLESCENTS
- A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder
- MEGADOSE INTRANASAL METHYLPHENIDATE (RITALIN) ABUSE IN ADULT ATTENTION DEFICIT HYPERACTIVITY DISORDER
- Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway
- AN OPEN TRIAL OF PEMOLINE IN DRUG-DEPENDENT DELINQUENTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER